Coverage
-
March 22, 2019
Two firms serving as class counsel in a junk fax settlement with Vertex Pharmaceuticals should receive less than they requested in fees because they overstated the $4.75 million deal's benefit to the class, a Massachusetts federal judge has ruled.
1 other articles on this case.
View all »